Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude.
Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects.
Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis.
Power estimation for non-standardized multisite studies.
Multiple sclerosis: an immune or neurodegenerative disorder?
Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE.
Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
Rituximab Use in Pediatric Central Demyelinating Disease.
Current and future disease-modifying therapies in multiple sclerosis.
Clinical profile of malay children with optic neuritis.
Regulation of prefrontal cortex myelination by the microbiota.
Oxidative modification of serum proteins in multiple sclerosis.
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis.
Immunology 2014
Optimizing IFN Beta - 1B Dose (Optims)
BRIEF-Health Canada approves Genzyme's Aubagio to treat relapsing remitting multiple sclerosis
Imaging outcomes for trials of remyelination in multiple sclerosis.
The Clinical Meaning of Walking Speed as Measured by the Timed 25-Foot Walk in Patients With Multiple Sclerosis.
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS.
Fourth PML Case With Tecfidera in MS Calls for Vigilance
Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench.
1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.
Treatment of neuromyelitis optica.
Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis.

Pages